Loading…

LANXESS plans to expand production capacity for Oxone monopersulfate at its Memphis, USA facility by about 50%, with an investment in the lower double-digit million euro range. Completion is expected in the second half of 2022.
“Disinfection products are important growth drivers in our highly profitable Consumer Protection segment.”lanxess.com
Summarized from public sources; check the original articles before acting on it.